Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 84051-84100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05157126
Gentamicin Open Tibia Study
PHASE4Recruiting
890 participants
Started: Sep 1, 2022 · Completed: Apr 30, 2029
1 condition4 sponsors1 location
NCT06154811
Exploring the Use of Pulse Tissue Doppler in Predicting Extubation Success in Mechanically Ventilated Patients
N/ARecruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05470335
Nurse-led Sheath Insertion in Cardiac Patients
NARecruiting
1,000 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05293067
Troponin in Carotid Revascularization
N/AActive, not recruiting
320 participants
Started: Sep 1, 2022 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT05204472
Thalamic-Burst-DBS for Neuropathic Pain
NARecruiting
20 participants
Started: Sep 1, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05548946
A Dimensional Model for Personality Disorders in Later Life
NARecruiting
750 participants
Started: Sep 1, 2022 · Completed: Nov 30, 2025
1 condition5 sponsors2 locations
NCT05842317
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC
PHASE1/PHASE2Recruiting
60 participants
Started: Sep 1, 2022 · Completed: Nov 15, 2024
1 condition1 sponsor1 location
NCT05584397
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
N/AEnrolling by invitation
40 participants
Started: Sep 1, 2022 · Completed: Dec 28, 2025
4 conditions3 sponsors1 location
NCT05417555
Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
NARecruiting
144 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2026
4 conditions2 sponsors1 location
NCT04835493
Evaluating Telementoring for CHW-centered Diabetes Initiatives
NAActive, not recruiting
320 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2028
1 condition5 sponsors1 location
NCT05450835
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
NARecruiting
344 participants
Started: Sep 1, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor12 locations
NCT06088134
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
N/ARecruiting
800 participants
Started: Sep 1, 2022 · Completed: Aug 1, 2025
3 conditions1 sponsor1 location
NCT06081296
Dimensional Changes in Alveolar Ridge Preservation
NARecruiting
80 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2024
1 condition1 sponsor1 location
NCT05280067
ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONES
PHASE2Active, not recruiting
10 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06140862
"Ankle Spine Syndrome RAFFET Syndrome II"
NAActive, not recruiting
1,000 participants
Started: Sep 1, 2022 · Completed: Jan 25, 2024
4 conditions1 sponsor1 location
NCT06589401
Oral Paclitaxel for Patients with Advanced Solid Tumors
PHASE1Recruiting
70 participants
Started: Sep 1, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04845490
Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
PHASE2Not yet recruiting
201 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2026
5 conditions1 sponsor0 locations
NCT05141396
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
NARecruiting
13,400 participants
Started: Sep 1, 2022 · Completed: Oct 15, 2026
1 condition3 sponsors11 locations
NCT05362344
Colorectal Cancer Screening in Cystic Fibrosis
N/AActive, not recruiting
350 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2026
3 conditions2 sponsors26 locations
NCT05237089
Effect of Electroacupuncture on Obesity
NARecruiting
256 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05482165
Optimizing Intervention Effects in Children and Adolescents
NAActive, not recruiting
1,627 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT07046156
Treatment of Overactive Bladder With Anticholinergic Agents
N/AActive, not recruiting
120 participants
Started: Sep 1, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06147388
Regression of Cervical Precancerous Lesions and Associated Risk Factors
N/ARecruiting
300 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2027
4 conditions1 sponsor1 location
NCT05439330
Application of a Dental-dedicated MRI in the Diagnosis of Temporomandibular Joint Disorders, Tissue Alterations Related to Third Molars, Periapical and Periodontal Inflammatory Diseases, and Implant Treatment Planning
NARecruiting
470 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
5 conditions3 sponsors1 location
NCT05600868
The Effect of Dual Attention in an EMDR Intervention
NAEnrolling by invitation
100 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05190744
Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
PHASE2Recruiting
36 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06186947
Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health
N/ARecruiting
5,000 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
1 condition26 sponsors1 location
NCT06179121
"Adding DNA-test for Screening of HLA-DQ2 and DQ8 to Improve Early Diagnosis of Celiac Disease"
N/AEnrolling by invitation
508 participants
Started: Sep 1, 2022 · Completed: Nov 1, 2024
1 condition2 sponsors1 location
NCT05717413
New Method of Surgical Treatment of Patients With Osteoarthritis of the 1st Metatarsophalangeal Joint
N/ARecruiting
46 participants
Started: Sep 1, 2022 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT05689775
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
N/ARecruiting
40 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT06423651
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
NARecruiting
160 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
6 conditions13 sponsors1 location
NCT05876390
Impact of Regional Anesthesia on Chronic Post-operative Pain
N/AEnrolling by invitation
1,500 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06185036
Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint
N/ARecruiting
25 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05355389
Cognitive-motor Telerehabilitation in MS
NARecruiting
90 participants
Started: Sep 1, 2022 · Completed: May 31, 2027
1 condition3 sponsors2 locations
NCT05590442
Risk Model of Cognitive Impairment in Diabetes
N/ARecruiting
500 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05615766
Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation
NARecruiting
9 participants
Started: Sep 1, 2022 · Completed: Mar 31, 2026
1 condition4 sponsors2 locations
NCT05505227
Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing
NAActive, not recruiting
400 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
4 conditions4 sponsors1 location
NCT06506071
Characterization of Acute Myocardial Damage With Spectral Computed Tomography. (CADAMI-SPECTRAL)
N/ARecruiting
300 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2025
4 conditions2 sponsors1 location
NCT03663153
SEMA4C as a Relapse Biomarker in Breast Cancer
N/ANot yet recruiting
4,200 participants
Started: Sep 1, 2022 · Completed: Aug 1, 2026
1 condition7 sponsors0 locations
NCT06150482
Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study
N/ARecruiting
600 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT05572983
Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
PHASE2Recruiting
47 participants
Started: Sep 1, 2022 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT06822413
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
N/ARecruiting
600 participants
Started: Sep 1, 2022 · Completed: Jul 28, 2025
17 conditions4 sponsors4 locations
NCT06403163
Transfusion Surveillance in Anaesthesia
N/ARecruiting
50,000 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2030
8 conditions1 sponsor1 location
NCT05514327
A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL
NARecruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 1, 2024
4 conditions1 sponsor1 location
NCT05571618
The Rechallenge of ADCs in MBC Patients
N/AActive, not recruiting
100 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT04949750
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
NAActive, not recruiting
200 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2025
1 condition4 sponsors1 location
NCT05248516
ComPAS Low-WAZ RCT Mali
PHASE2/PHASE3Active, not recruiting
1,500 participants
Started: Sep 1, 2022 · Completed: Apr 30, 2024
3 conditions3 sponsors11 locations
NCT05521204
Olverembatinib for FGFR1-rearranged Neoplasms
PHASE2Recruiting
20 participants
Started: Sep 1, 2022 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT06594107
Factors for the Onset and Course of Axial Spondylitis
N/ARecruiting
1,000 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2035
1 condition2 sponsors2 locations
NCT05508932
Atrial Fibrillation in Beta-Thalassemia
N/ARecruiting
350 participants
Started: Sep 1, 2022 · Completed: Jul 1, 2032
2 conditions1 sponsor1 location